CanadaPharma - Page 10

Learn the difference between internal and external hemorrhoids, what causes them, and the most effective treatments-from home remedies to medical procedures. Stop guessing and start fixing.

Learn how to prepare for a telehealth medication review, what questions to ask, and how to avoid dangerous drug interactions. A practical guide to safer virtual pharmacy consultations.

Muscle cramps on statins can be myopathy or neuropathy-two very different issues. Learn how to tell them apart, what tests to ask for, and how to protect your heart without sacrificing muscle health.

Discover how physical therapy using exercise, stretching, and movement can reduce pain naturally-without drugs. Learn proven techniques, real results, and how to start today.

Many people skip doses or skip refills because they can't afford their meds. Learn why cost is the #1 barrier to medication adherence-and what real, working solutions exist right now to help you get the drugs you need without going broke.

Learn how allopurinol and febuxostat help control gout by lowering serum urate to target levels below 6 mg/dL. Understand dosing, side effects, and why most patients fail to reach their goals.

Discover how weight loss and GLP-1 drugs like semaglutide can reverse fatty liver disease. Learn the science behind MASLD, what actually works, and how to take action today.

Vertigo isn't just dizziness - it's a spinning sensation often caused by inner ear problems like BPPV. Learn how vestibular therapy, the Epley maneuver, and lifestyle changes can restore balance without drugs.

Steroid myopathy causes painless, proximal muscle weakness in people on long-term corticosteroids. Learn how to recognize it early, why it’s often missed, and how physical therapy can safely rebuild strength without worsening damage.

GDUFA is the law that lets the FDA collect fees from generic drug makers to speed up approvals. Since 2012, it's cut review times, reduced backlogs, and kept affordable medicines flowing to patients.

Generic drug shortages are caused by manufacturing failures, global supply chain concentration, lack of backup capacity, and profit-driven market pressures. Over 95% of shortages involve generics, with most stemming from single-source production and low margins.

CYP2C9 and VKORC1 gene variants significantly affect warfarin dosing and bleeding risk. Genetic testing can reduce dangerous side effects by up to 32% in the first 90 days of therapy.